Biologics and cell therapy programs are under increasing pressure to deliver high‑quality cell lines and physiologically meaningful 3D models—faster, more consistently, and with full traceability. Yet ...
AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM for integrating the Leap-In transposase expression platform into its services. With this ...
Peer-reviewed study demonstrates precision genome editing, stable integration, and high-producing CHO platforms for commercial biomanufacturingLEXINGTON, Ky.--(BUSINESS WIRE)--Demeetra AgBio (Demeetra ...
The "Cell Line Characterization and Cell Line Development Market Industry Trends and Global Forecasts to 2035: Distribution by Source of Cell Line / Expression System, Application of Cell Line, ...
New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...
DURHAM, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (SCPX) (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract ...
Synthetic bio company Asimov agreed to collaborate with Cytiva to provide customers with an integrated offering for optimized biologics production. Access includes Asimov’s CHO Edge cell line ...
The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, Sept. 15, 2025 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO for complex biologics and ...
Sartorius has launched a new genetically engineered CHO host cell line designed to improve productivity and efficiency.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results